DUBLIN, December 02, 2025--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...
As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business ...
GreensKeeper Asset Management, an investment management company, released its third-quarter 2025 investor letter. A copy of ...
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 ...
Wondering if ICON is quietly trading below what it is really worth, especially after a choppy few years in healthcare stocks? This breakdown will help you decide if it deserves a spot on your ...
MannKind Corporation ($MNKD) announced an update on their ongoing clinical study. Study Overview: The ICoN-1 Phase 3 study, officially titled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback